PUBLICATIONS
PEER-REVIEWED ARTICLES
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
Brener SJ, Prasad AJ, Abdula R, Sacchi TJ. Relationship Between the Angiographically Derived
SYNTAX Score and Outcomes in High-Risk Patients Undergoing Percutaneous Coronary
Intervention. J Invasive Cardiology 2011; 23:66-9
Parikh PB, Jeremias A, Naidu SS, Brener SJ, Shlofmitz RA, Pappas, T, Marzo, KP, Gruberg, L. Effect
of Gender and Race on Outcomes in Dialysis-Dependent Patients Undergoing Percutaneous
Coronary Intervention. Am J Cardiol 2011.
Domanski MJ, Mahaffey K, Hasselbad V, Brener SJ, Smith PK, Hillis G, Engoren M, Alexander JH,
Levy JH, Chaitman B, Broderick S, Mack MJ, Pieper KJ, Farkouh ME. Association of Myocardial
Enzyme Elevation and Survival Following Coronary Artery Bypass Graft Surgery. JAMA 2011;
305:585-91
Brener SJ, Prasad AJ, Khan Z, Sacchi TJ. The relationship between late lumen loss and restenosis
among various drug-eluting stents: A systematic review and meta-regression analysis of
randomized clinical trials. Atherosclerosis 2011; 214:158-62
Brener SJ. Is Implantation of Drug-Eluting Stents a Faustian Choice? J Invasive Cardiology 2010;
22:465-6
Brener SJ. What does chronic oral anticoagulation after myocardial infarction actually prevent?
Am J Med 2010; 123(11):e15
Heitner JF, Bhumireddy GP, Cawley PJ, Klem I, Manesh RP, Crowley AL, Weinsaft JW, Elliott M,
Parker M, Brener S, Judd RM, Kim RJ. The aorta wall of patients presenting to the emergency
department with acute myocardial infarction by cardiac magnetic resonance. Atherosclerosis
2010; 212:166-70
Brener SJ. Why We Do What We Do? Making Sense of Antithrombotic Therapy in Patients With
Non_ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary
Intervention. J Am Coll Cardiol Interv 2010; 3:678-9
Alhadramy, O, Westerhout CM, Brener SJ, Granger CB, Armstrong PW. Is visual interpretation of
coronary epicardial flow reliable in patients with ST-elevation myocardial infarction undergoing
primary angioplasty? Insights from the angiographic substudy of the Assessment of Pexelizumab in
Acute Myocardial Infarction (APEX-AMI) trial. Am Heart J 2010; 159:899-904
Haq SA, Heitner JF, Sacchi TJ, Brener SJ. Long-term Effect of Chronic Oral Anticoagulation with
Warfarin after Acute Myocardial Infarction. Am J Med 2010; 123:250-8
Brener SJ. Research Highlights. Interventional Cardiology 2010; 2:17-20
Brener SJ, Colombo KD, Haq SA, Bose S, Sacchi TJ. Precision and accuracy of risk scores for inhospital death after percutaneous coronary intervention in the current era. Cathet Cardiovasc
Interv 2010; 75:153-7
Brener SJ. Measuring the right compound at the right time is not always easy. J. Invasive
Cardiology 2010; 22:6-7
Brener SJ, Haq SA, Bose S, Sacchi TJ. Three-year Survival after Percutaneous Coronary Intervention
According to Appropriateness Criteria for Revascularization. J Invasive Cardiology 2009; 21:554-7
Brener SJ. Antithrombin Therapy for Elective Percutaneous Coronary Intervention. Which Agent to
Use? Does It Matter? J Am Coll Cardiol Interv 2009; 2:1092-4
Brener SJ, Westerhout CM, Fu Y, Todaro TG, Moliterno DJ, Wagner GS, Granger CB, Armstrong PW
for the APEX-AMI Investigators. Contribution of angiographic and electrocardiographic parameters
of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial. Am
Heart J 2009; 158:755-60
Brener SJ. The Benefits of Platelet Glycoprotein IIb/IIIa Receptor Inhibition During Primary
Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: DrugSpecific or Class Effect? J Am Coll Cardiol 2009; 53:1674-6
Bhatt DL, Peterson ED, Harrington RA, Ou F-S, Cannon CP, Gibson CM, Kleiman NS, Brindis RG,
Peacock WF, Brener SJ, Menon V, Smith SC Jr, Pollack CVJr, Gibler WB, Ohman EM, Roe MT. Prior
Polyvascular disease: a risk factor for adverse ischemic outcomes in acute coronary syndromes.
Eur Heart J 2009; 30:1195-202
Brener SJ, Bhatt DL. The pain and the gain of treating patients with acute coronary syndromes –
can the two be separated? Am Heart J 2009; 157:399-401
Prasad AJ, Schwartzman RA and Brener SJ. Quantitative Coronary Angiography versus
Intravascular Ultrasound for the Evaluation of Plaque Regression in Coronary Artery Disease. Have
We
Reached
"Imaging
Heaven"?
2009,
Feb.
2;
http://www.athero.org/commentaries/comm877.asp
Schwartzman RA, Brener SJ. Management of multivessel CAD in ACS patients: Do not leave for
tomorrow what you can finish today. Cardiology Review 2008; 25:33
Bexell D, Setser RM, Schoenhagen P, Lieber ML, Brener SJ, Ivanc TB, Balasz EM, O’Donnell TP,
stillman AE, Arheden H, Wagner GS, White RD. Influence of Coronary Artery Stenosis Severity and
Coronary Collateralization on Extent of Chronic Myocardial Scar: Insights from Quantitative
Coronary Angiography and Delayed-Enhancement MRI. Open Cardiovascular Medical Journal
2008; 2:79-86
Shishebor MH, Goel SS, Kapada SR, Bhatt DL, Kelly P, Raymond RE, Galla JM, Brener SJ, Whitlow
PL, Ellis SG. Long-term impact of drug-eluting stents versus bare-metal stents on all-cause
mortality. J Am Coll Cardiol 2008; 52:1041-8
Shishebor MH, Amini R, Raymond RE, Bavry AA, Brener SJ, Kapadia SR, Whitlow PL, Ellis SG, Bhatt
DL. Safety and efficacy of overlapping sirolimus-eluting versus paclitaxel-eluting stent. Am Heart J
2008; 155:1075-80
Mahaffey KW, Resit CJ, Fu Y, Brener SJ, Theroux P, Patel MR, Stebbins A, Westerhout CM, Todaro
TG, Adams PX, Granger CB, Armstrong PW. Integrating ancillary studies in a large clinical trial. The
design and rationale of the APEX library. Contemp Clini Trials 2008; Jul 1
Shishebor MH, Amini R, Oliveria LPJ, Singh IM, Kelly P, Bhatt DL, Kapadia SR, Ellis SG, Whitlow PW,
Brener SJ. Comparison of drug-eluting stents versus bare-metal stents for treating of ST-segment
elevation myocardial infarction. J Am Coll Cardiol Interv 2008; 1:227-32
Brener SJ, Ivanc TB, Hu T. The relation between extent of coronary artery disease measured by
quantitative coronary angiography and changes in lipid profile: Insights from trial of
atherosclerosis regression. J Invasive Cardiology 2008; 20:261-5
Ballantyne CM, Raichlen JS, Nicholls SJ, Erbel R, Tardif J-C, Brener SJ, Cain VA, Nissen SE for the
ASTEROID Investigators. Effect of rosuvastatin on coronary artery stenoses assessed by
quantitative coronary angiography. A study to evaluate the effect of rosuvastatin on intravascular
ultrasound-derived coronary atheroma burden. Circulation 2008; 117:2458-66
Brener SJ, Moliterno DJ, Aylward PE, van’t Hof AWJ, Ruzyllo W, O’Neill WW, Hamm CW,
Westerhout CM, Granger CB, Armstrong PW for the APEX-AMI Investigators. Reperfusion after
primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship
to clinical outcomes in the APEX-AMI Angiographic Study. Eur Heart J 2008; 29:1127-35
30. Brener SJ, Galla JM, Bryant R, Sabik JF, Ellis SG. Comparison of Percutaneous versus Surgical
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
Revascularization of Severe Unprotected Left Main Coronary Stenosis in Matched Patients. Am J
Cardiol 2008; 101:169-72
Brener SJ, Milford-Beland S, Roe MT, Bhatt DL, Weintraub WS, Brindis RG. Culprit-only or
multivessel revascularization in patients with acute coronary syndromes; An ACC-NCDR report. Am
Heart J 2008; 155:140-6
Brener SJ, Steinhubl SR; Berger PB; Brennan DM, Topol EJ. Prolonged dual antiplatelet therapy
after percutaneous coronary intervention reduces ischemic events without affecting the need for
repeat revascularization; Insights from the CREDO trial. J Inv Cardiol 2007; 19:287-90
Shishebor M, Lauer MS, Singh IM, Chew DP, Karha J, Brener SJ, Moliterno DJ, Ellis SG, Topol EJ,
Bhatt DL. In unstable angina or non-ST segment acute coronary syndromes, should patients with
multivessel coronary disease undergo multivessel or culprit-only stenting? J Am Coll Cardiol 2007;
49:849-54
Thygesen K, Alpert JS, White HD, …….Brener S, ……Dudek D, Al-Atar N. Universal definition of MI.
Circulation 2007; 116:2634-53
Exaire JE. Fathi RB. Brener SJ. Karha J. Ellis SG. Bhatt DL. Impaired myocardial perfusion score and
inflammatory markers in patients undergoing primary angioplasty for acute myocardial infarction.
Archivos de Cardiologia de Mexico. 2006; 76(4):376-82
Brener SJ, Ivanc TB, Poliszczuk R, Chen M, Tuzcu EM, Hu T, Frid DJ, Nissen SE. Antihypertensive
Therapy and Regression of Coronary Artery Disease. Insights from the CAMELOT and NORMALISE
Trials. Am Heart J 2006; 152: 1059
Karha J, Gurm HS, Rajagopal V, Fathi R, Bavry AA, Brener SJ, Lincoff AM, Ellis SG, Bhatt DL. Use of
platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention
and clinical outcome. Am J Cardiol 2006; 98:906
Saw J, Bhatt DL, Moliterno DJ, Brener SJ, Steinhubl SR, Lincoff AM, Tcheng JE, Harrington RA,
Simoons M, Hu T-F, Sheikh MA, Kereiakes DJ, Topol EJ. The influence of peripheral arterial disease
on outcomes. A pooled analysis of mortality in eight large randomized percutaneous coronary
intervention trials. J Am Coll Cardiol 2006; 48:1567
Karha J, Bavry AA, Rajagopal V, Henderson MR, Ellis SG, Brener SJ. Relation of C-Reactive Protein
Level and Long-Term Risk of Death or Myocardial Infarction Following Percutaneous Coronary
Intervention with a Sirolimus-Eluting Stent. Am J Cardiol 2006; 98:616-8
Brener SJ. Insights into the pathophysiology of ST-elevation myocardial infarction. Am Heart J
2006; 151:S4-S10
Brener SJ. To stent or to operate: Is this the question? Clev Clin J Med 2006; 73:340-3
Brener SJ. Wish list and REALITY: Choice of stents and end points for treatment of de novo
coronary artery lesions. JAMA 2006; 295:937-8
Brener SJ, Lytle BW, Casserly IP, Ellis SG, Topol EJ, Lauer MS. Predictors of revascularization
method and long-term outcome of percutaneous coronary intervention or repeat coronary bypass
surgery in patients with multivessel coronary disease and previous coronary bypass surgery. Eur
Heart J 2005; 26:413-18
Karha J, Hook MA, Brener SJ. Primary Percutaneous PCI for Acute MI: Improving Access and
Outcomes. Clev Clin J Med 2005; 72:559-76
Brener SJ, Lincoff AM, Bates ER, Jia G, Armstrong PW, Guetta V, Hichman JS, Savonito S, Wilcox
RW, White HD, Topol EJ. The relationship between baseline risk and mortality in ST-elevation
acute myocardial infarction treated with pharmacological reperfusion. Insights from the GUSTO V
trial. Am Heart J 2005; 150:89-93
46. Karha J, Exaire JE, Rajagopal V, Ivanc TB, Kapadia SR, Ellis SG, Brener SJ. Relation of myocardial
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
perfusion to mortality after primary percutaneous coronary intervention. Am J Cardiol 2005;
95:980-2
Exaire JE, Brener SJ, Ellis SG, Yadav JS, Bhatt DL. GuardWire emboli protection device is associated
with improved myocardial perfusion grade in saphenous vein graft intervention. Am Heart J 2004;
148:1003-6
Ellis SG, Bajzer CT, Bhatt DL, Brener SJ, Whitlow PL, Lincoff AM, Moliterno DJ, Raymond RE, Tuzcu
E, Franco I, Dushman-Ellis S, Lander KJ, Schneider JP, Topol EJ. Real-world bare metal stenting:
Identification of patients at low or very low risk of 9-month coronary revascularization. CCI 2004;
63:135
Brener SJ, Moliterno DJ, Lincoff AM, Steinhubl SR, Wolski KE, Topol EJ. Relationship between
Activated Clotting Time and ischemic or hemorrhagic complications. Analysis of four recent
randomized clinical trials of percutaneous coronary intervention. Circulation 2004; 110:994-8
Brener SJ, Lytle BW, Casserly IP, Schneider JP, Topol EJ, Lauer MS. Propensity Analysis of LongTerm Survival After Surgical or Percutaneous Revascularization in Patients With Multivessel
Coronary Artery Disease and High-Risk Features. Circulation 2004; 109:2290-5
Kandzari DE, Hasselbad V, Tcheng JE, Stone GW, Califf RM, Kastrati A, Neumann F-J, Brener SJ,
Montalescot G, Kong DF, Harrington RA. Improved clinical outcomes with abciximab therapy in
acute myocardial infarction: A systematic overview of randomized clinical trials. Am Heart J 2004;
147:457-62
Brener SJ, Topol EJ. Adjunctive therapy for percutaneous revascularization in acute myocardial
infarction. Curr Pharm Design 2004; 10:399-406
Ellis K. and Brener SJ. New fibrinolytic agents for MI: As effective as current agents but easier to
administer. Clev Clin J Med 2004; 71:20-37
Brener SJ, Bhatt DL, Moliterno DJ, Schneider JP, Ellis SE, Topol EJ. Revisiting optimal
anticoagulation with unfractionated heparin during coronary stent implantation. Am J Cardiol
2003; 92:1468-71
Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, Ellis SG, Lincoff AM, Topol EJ.
Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003;
290:898-904
Girod, JP, Messerli AW, Zidar F, Tang WHW and Brener SJ. Tako-Tsubo–Like Transient Left
Ventricular Dysfunction. Circulation 2003; 107:e120-1
Cho L, Chew DP, Moliterno DJ, Brener SJ, et al. Safe and efficacious use of bivalirudin for
percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor
inhibition. Am J Cardiol 2003;91:742-3
Cura FA, Kapadia SR, L'Allier PL, Ziada KM, Mukherjee D, Wolski KE, Yadav JS, Brener SJ, Whitlow
PL, Topol EJ, Ellis SG: Effect of uncoated stenting versus balloon angioplasty alone of long coronary
(>20 mm) versus shorter narrowings on One-Year Event-Free survival. Am J Cardiol 2003; 91(5):
587-90.
Brener SJ, Midei MG, Nukta ED, Kereiakes DJ, Rizik DG, Murphy D, Brennan D, Moliterno DJ, Topol
EJ, for the CONSERVE Investigators: A Randomized Multicenter Trial Comparing a New, LowPressure Versus a Conventional Coronary Stent: Primary Results from the CONSERVE Trial. J Invas
Cardiol 2003; 15: 128-32
Brener SJ, Ellis SG, Schneider JP, Apperson-Hansen C, Topol EJ: Abciximab-facilitated percutaneous
coronary intervention and long-term survival – A prospective single-center registry. Eur Heart J
2003; 24:630-38
61. Brener SJ: Combination platelet and fibrin lysis for acute myocardial infarction. Cardiov Rev Rep
2003; 24:136-43
62. Vivekanathan, DP, Brener SJ. Recurrent subacute stent thrombosis precipitated by carbon
monoxide poisoning. www.clevelandclinic.org 2002
63. Brener SJ, Lytle BW, Schneider JP, Ellis SG, Topol EJ: Association between CK-MB elevation
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
following percutaneous or surgical revascularization and 3-year mortality. J Am Coll Cardiol 2002;
40:1961-7
Jeremias A, Albirini A, Ziada KM, Chew DP, Brener SJ, Topol EJ, Ellis SG. Prognostic significance of
creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic
renal dysfunction. Am Heart J 2002; 143(6): 1040-5
Quinn, MJ and Brener SJ. Early invasive strategies for acute coronary syndromes. Current
Cardiology Reports 2002; 4(4): 334-40
Brener SJ, Murphy SA, Gibson CM, DiBattiste PM, Demopoulos LA, Cannon CP: Efficacy and Safety
of Multivessel Percutaneous Revascularization and Tirofiban Therapy in Patients with Acute
Coronary Syndromes. Am J Cardiol 2002; 90:631-3
Brener SJ, Ellis SG, Schneider J. and Topol.EJ: Frequency and long-term impact of myonecrosis
after coronary stenting. Eur Heart J 2002; 23:869-76
Jeremias A, Bhatt DL, Chew DP, Ziada KM, Albirini A, Brener SJ, Lincoff AM, Topol EJ, Ellis SG.
Safety of Abciximab During Percutaneous Coronary Intervention In Patients With Chronic Renal
Insufficiency. Am J Cardiol 2002; 89:1209-11
Brener SJ, Zeymer U, Adgey, AAJ, Vrobel, TR, Ellis SG, Neuhaus, K-L, Juran N, Ivanc TB, Ohman, EM,
Strony J, Kitt M, Topol EJ, for the INTRO AMI Investigators: Eptifibatide and low-dose tissue
plasminogen activator in acute myocardial infarction: The Integrilin and Low-Dose Thrombolysis in
Acute Myocardial Infarction - INTRO AMI TRIAL. J Am Coll Cardiol 2002; 39:377-86.
Ellis SG, Brener SJ, Lincoff AM, Moliterno DJ, Whitlow PL, Schneider JP, Topol EJ: ß-Blockers Before
Percutaneous Coronary Intervention Do Not Attenuate Postprocedural Creatine Kinase Isoenzyme
Rise. Circulation 2001 104: 2685 - 2688.
Albirini A. and Brener SJ: Platelet glycoprotein IIb/IIIa inhibition in primary angioplasty for acute
myocardial infarction: The new paradigm of direct revascularization. Int J Cardiovasc Interv 2001;
4:7-14
Brener SJ and Topol EJ: Epicardial vs. microcirculatory dissociation. Eur Heart J 2002; 23:274-6
Cura FA, L’Allier PL, Kapadia SR, Houghtaling PL, DiPaola LM, Ellis SG, Topol EJ and Brener SJ:
Predictors and prognosis of suboptimal coronary blood flow after primary coronary angioplasty in
patients with acute myocardial infarction. Am J Cardiol 2001; 88:124-8
Chan AW and Brener SJ: Appropriate use of glycoprotein IIb/IIIa blockade for unstable angina and
non-ST segment elevation myocardial infarction. JCOM 2001; 8:33-45
Chew DP, Bhatt DL, Lincoff AM, Moliterno DJ, Brener SJ, Wolski KE, Topol EJ: Defining the optimal
activated clotting time during percutaneous coroanry intervention. Aggregate results from 6
randomized, controlled trials. Circulation 2001; 103:961-6
Brener SJ and Topol EJ: Troponin, embolization and restoration of microvascular integrity. Eur
Heart J 2000; 21:1117-9
Cura FA, Bhatt DL, Lincoff AM, Kapadia SR, L’Allier PL, Ziada KM, Wolski KE, Moliterno DJ, Brener
SJ, Ellis SG, Topol EJ: Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein
IIb/IIIa inhibition in complex atherosclerotic lesions. Circulation 2000;102:28-34
Bhatt DL, Lincoff AM, Califf RM, Simoons ML, Tcheng JE, Brener SJ, Wolski KE, Topol EJ: The
benefit of Abciximab in percutaneous coronary revascularization is not device-specific. Am J
Cardiol 2000; 85:1060-4
79. Brener SJ, Ellis SG, Sapp SK, Betriu A, Granger CB, Burchenal JEB, Moliterno DJ, Califf RM, Topol EJ,
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
94.
for the GUSTO IIb and RAPPORT Investigators: Predictors of death and reinfarction at 30 days after
primary angioplasty: The GUSTO IIb and RAPPORT trials. Am Heart J 2000;139:476-81
Penn MS, Smedeira N, Lytle BW, Brener SJ: Does coronary angiography before emergency aortic
surgery affect in-hospital mortality? J Am Coll Cardiol 2000; 35:889-94
Brener SJ: Unfractionated and low-molecular-weight heparins in acute coronary syndromes:
Current recommendations. Clev Clin J Med 2000; 67:59-65
Robbins MA, Marso SP, Wolski KE, Peterson J, Lincoff AM, Brener SJ: Chest pain – A strong
predictor of adverse cardiac events following percutaneous intervention (from the Evaluation of
Platelet IIb/IIIa Inhibitor for Stenting Trial [EPISTENT]). Am J Cardiol 1999; 84:1350-3
Brener SJ and Topol EJ: Logic and Logistics: Conundrum in reperfusion treatment for acute
myocardial infarction. Heart, 1999; 82:402-3
Bahler RC, Dresser DR, Finkelhor RS, Brener SJ, Youseffi MY: Factors Leading to Progression of
Valvular Aortic Stenosis. Am J Cardiol 1999; 84:1044-8
Brener SJ, Barr LA, Burchenal JEB, Wolski KE, Effron MB, Topol EJ, for the RAPPORT Investigators:
Effect of abciximab on the Pattern of Reperfusion in Patients with Acute Myocardial Infarction
Treated with Primary Angioplasty. Am J Cardiol 1999; 84:729
Pfisterer M, Cox JL, Granger CB, Brener SJ, Naylor CD, Califf RM, van de Werf F, Stebbins AL, Lee
KL, Topol EJ, Armstrong PW, for the GUSTO-I Investigators: Atenolol use and clinical outcomes
after thrombolysis for acute myocardial infarction: The GUSTO-I experience. J Am Coll Cardiol
1998; 32:634-40
Brener SJ. Angioplasty or fibrinolysis for acute MI? The GUSTO IIB study. Clev Clin J Med 1998;
65:75-81
Brener SJ, Barr LA, Burchenal JEB, Katz S, George BS, Jones AA, Cohen ED, Gainey PC, White HJ,
Cheek HB, Moses JW, Moliterno DJ, Effron MB, Topol EJ, for the ReoPro and Primary PTCA
Organization and Randomized Trial (RAPPORT) Investigators: A Randomized, Placebo-Controlled
Trial of Platelet Glycoprotein IIb/IIIa Blockade with Primary Angioplasty for Acute Myocardial
Infarction. Circulation 1998; 98:734-41
Brener SJ, Loop FD, Lytle BW, Ellis SG, Cosgrove DM, Topol EJ: A Profile of Candidates for Repeat
Myocardial Revascularization: Implications for Selection of Treatment. J Thor Cardiovsc Surg 1997,
114:153-61
Ellis SG, Brener SJ, DeLuca SA, Tuzcu EM, Raymond RE, Whitlow PL, Topol EJ: Late Myocardial
Ischemic Events After Saphenous Vein Graft Intervention - Importance of Initially “Nonsignificant”
Vein Graft Lesions. Am J Cardiol 1997; 79:1460-4
Brener SJ, Ellis, SG, Apperson-Hansen C, Leon MB, Topol EJ: Percutaneous Coronary
Revascularization of Saphenous Vein Grafts. A comparison of Stenting with Balloon Angioplasty.
Am J Cardiol 1997; 79:13-8
Brener SJ, Leya FS, Apperson-Hansen C, Cowley MJ, Califf RM, Topol EJ: A Comparison of
Debulking Versus Dilatation of Bifurcation Coronary Lesions. Lessons from the CAVEAT I Trial. Am J
Cardiol 1996; 78:1039-41
Ellis SG, Hertzer NR, Young JR, Brener SJ: Angiographic and Clinical Correlates of Cardiac Death and
Myocardial Infarction Complicating Major Peripheral Vascular Surgery: The Importance of
"Inadequate" Collaterals and "Non-Obstructive " Lesions. Am. J. Cardiol 1996; 77:1126-8
Brener SJ, Paskow FJ, Harvey SA, Marwick TH, Thomas JD, Lauer MS: Chronotropic Response to
Exercise Predicts Angiographic Severity in Patients with Suspected or Stable Coronary Artery
Disease. Am. J. Cardiol 1995; 76:1228-32
95. Benbadis SR, Wolgamuth BR, Goren H, Brener SJ, Fouad-Tarazi FM: Value of Tongue Biting in the
Diagnosis of Seizures. Arch Int Med 1995; 155:2346-9
96. Brener SJ, Duffy CI, Thomas JD, Stewart WS: Progression of Aortic Stenosis in 394 Patients:
97.
Relation to Changes in Myocardial and Mitral Valve Dysfunction. J Am Coll Cardiol 1995; 25:305310
Jaeger FJ, Trohman R, Brener SJ, Loop FD: Permanent Pacing Following Repeat Cardiac Valve
Surgery. Am. J. Cardiol 1994; 74:505-508
BOOK CHAPTERS AND REVIEWS
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
Gimple S, Seshadri N, Hobbs RE, Brener SJ. Native Coronary Angiography, in Askari AT, Shishebor
MH, Messerli AW, Aviles RJ, eds. Inttroductory Guide to Cardiac Catheterization (2nd edition),
Philadelphia: Lippincott Williams & Wilkins 2011; Ch. 3 41-58
Grasso AW, Brener SJ. Complications of acute myocardial infarction. In Carey WD, ed. Current
Clinical Medicine (2nd edition), Philadelphia: Elsevier, 2010; Section 2 72-80
Christofferson RD, Brener SJ. Fibrinolysis and facilitated PCI, in Askari AT, Lincoff AM, eds.
Antithrombotic Drug Therapy in Cardiovascular Disease. New York, NY: Springer; 2010, Ch. 13:247260
Chhatriwalla AK and Brener SJ: Platelet Glycoprotein IIb/IIIa Receptor Blockade in Primary
Coronary Intervention, in Tcheng JE, ed. Contemporary Cardiology. Primary Angioplasty in Acute
Myocardial Infarction. (2nd edition) New York: Humana Press, 2009. Chapter 10, 169-94
Karha J, Brener SJ. Percutaneous coronary intervention for acute myocardial infarction. In Norell
MS, Perrins J, Meier B and Lincoff AM, eds. Essential Interventional Cardiology (2nd edition),
Philadelphia: Elsevier, 2008; Ch. 20:243-54
Brener SJ, Tschopp D. Complications of acute myocardial infarction. In Carey WD, ed. Current
Clinical Medicine 2009, Philadelphia: Elsevier, 2008; Section 2 103-110
Galla JM and Brener SJ: Anti-coagulation and post-procedural management. In Moliterno DJ, ed.
ACC/SCAI Cath SAP III 2008; Ch. 87:1031-8, www.cardiosource.com.
Brener SJ: Section Editor – Procedures. In Shishebor MH, Wang TH, Askari AT, Penn MS and Topol
EJ, eds. Management of the Patient in the Coronary Intensive Care Unit, Philadelphia: Lippincott
Williams & Wilkins, 2008; Chapters 26-30, 239-70
Karha J, Brener SJ: Fibrinolytic therapy for acute myocardial infarction. In Griffin BP, Rimmerman C
and Topol EJ, eds. The Cleveland Clinic Cardiology Board Review, Philadelphia: Lippincott Williams
& Wilkins, 2007; Chapter 16, 54-60
Brener SJ: Qualitative and quantitative angiography. In Mukherjee D, Cho L, Moliterno DJ, eds.
Interventional Cardiology. 900 Questions: An Interventional Cardiology Board Review,
Philadelphia: Lippincott Williams & Wilkins, 2006; Chapter 23, 181-4
Chhatriwalla A, Brener SJ: Plaque instability in acute coronary syndromes.
2006;
http://www.athero.org/commentaries/comm584.pdf
DeFranco AC, Tuzcu EM, Nissen SE and Brener SJ: Interventional applications of coronary
intravascular ultrasound, doppler flow and fractional flow reserve. In Fuster V, Topol EJ, Nabel EG,
eds. Atherotrhombosis and Coronary Artery Disease (2nd edition), Philadelphia: Lippincott Williams
& Wilkins, 2005. Chapter 91, 1363-88
Brener SJ and Topol EJ: Third-Generation Fibrinolytic Agents and Combined Fibrinoplatelet Lysis
for Acute Myocardial Infarction, in Topol EJ: Acute Coronary Syndromes (3rd ed.), Marcel Decker
2004, Ch. 10, 217
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
Brener SJ: Facilitated Coronary Intervention For Acute Myocardial Infarction, in Topol EJ: Acute
Coronary Syndromes (3rd ed.), Marcel Decker 2004, Ch. 12, 247
Gum PA, Brener SJ: Trials of acute myocardial infarction. In: Roffi M, Meier B, Topol EJ (eds):
CVMstat®. A Comprehensive Handheld-Based Approach to CardioVascular Medicine.
Handheldmed Inc., Little Rock, AR, USA, 2004.
Maroo A, Brener SJ. Pre-cath. In: Aviles RJ, ed. Introductory guide to cardiac catheterization..
Chapter 1. p. 1-15.
Seshadri N, Hobbs RE, Brener SJ. Native coronary angiography. In: Aviles RJ, ed. Introductory guide
to cardiac catheterization. Philadelphia: Lippincott Williams & Wilkins, 2004. Chapter 3. p. 39-58.
Yen M, Brener SJ. Setting up the lab. In: Aviles RJ, ed. Introductory guide to cardiac
catheterization. Philadelphia: Lippincott Williams & Wilkins, 2004. Chapter 2. p. 17-38.
Tschopp D, Brener SJ. Complications of acute myocardial infarction, in Cleveland Clinic Disease
Management Project; 2003, Web site: www.clevelandclinicmeded.com/diseasemanagement.
Brener SJ: Glycoprotein IIb/IIIa receptor blockade in acute myocardial infarction – adjunctive
therapy to fibrinolysis, in Lincoff AM: Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular
Medicine, 2nd ed. Totowa, NJ: Humana Press 2003, 289-302
Brener SJ, Topol EJ: Catheter-Based Reperfusion for Acute Myocardial Infarction, in Topol EJ:
Textbook of Interventional Cardiology 4th ed. Philadelphia: Elsevier Science 2003, 285-302
Albirini A and Brener SJ: Platelet Glycoprotein IIb/IIIa Receptor Blockade in Primary Angioplasty, in
Tcheng JE: Contemporary Cardiology. Primary Angioplasty in Acute Myocardial Infarction. Totowa:
Humana Press, 2002. Chapter 8, 117-38
Smith LK, Brener S, Pashkow FJ: Medical and invasive interventions in the management of
coronary artery disease. In: Roitman JL, ed. ACSM’s resource manual for guidelines for exercise
testing and prescription. 4th edition. Philadelphia: Lippincott Williams and Wilkins, 2001. Chapter
29, 254-62.
Brener SJ and Topol EJ: Third-Generation Thrombolytic Agents for Acute Myocardial Infarction, in
Topol EJ: Acute Coronary Syndromes (2nd ed.), Marcel Decker 2001, 243-70.
Brener SJ: Combination fibrinolysis and platelet IIb/IIIa antagonism for acute myocardial
infarction, in Topol EJ: Acute Coronary Syndromes (2nd ed.), Marcel Decker 2001, 271-92.
Brener SJ: Provisional use of abciximab during coronary angioplasty, in Ellis SG and Holmes DR:
Strategic approaches in coronary intervention (2nd ed.), Lippimcott Williams and Wilkins 2000;
574-9.
Brener SJ and Topol EJ: Primary Angioplasty, in Cannon, CP: Management of Acute Coronary
Syndromes, Humana Press 1999, 267-92.
L’Allier PL, Brener SJ, Whitlow PL: Rotational coronary atherectomy: Contemporary and future
applications. Current Interventional Cardiology Reports 1999; 1:291-7.
Brener SJ and Pashkow FJ: Medical and Invasive Interventions in the Treatment of Coronary Artery
Disease, in Roitman JLR: ACSM’s Resource Manual for Guidelines for Exercise Testing and
Prscription, William & Wilkins 1998, 246-53.
Brener SJ and Topol EJ: Third-Generation Thrombolytic Agents for Acute Myocardial Infarction, in
Topol EJ: Acute Coronary Syndromes, Marcel Decker 1998, 167-192.
Brener SJ and Ellis SG: Current Status of Rescue PTCA in Relation to Thrombolysis. Am J Cardiol
(Thrombolytic Therapy: New Standards of Care, Part IV), 1997; 24-30.
Brener SJ, Reifart N, Whitlow PL: Rotational Coronary Atherectomy: The status of three
randomized trials, in Holmes, DR and Serruys PW. Current Review of Interventional Cardiology, 3rd
edition, Current Medicine, Philadelphia, PA, 1997; 13-21.
Brener SJ and Ellis SG: Repeat revascularization in patients with prior CABG: Angioplasty or
surgery? ACC Current Journal Review 1997; 6:42-4.
34.
35.
36.
37.
Tuzcu EM, De Franco AC, Brener SJ, Nissen SE: Intravascular Ultrasound and Coronary Doppler
Flow Measurements in the Diagnosis of Coronary Artery Disease, in Marwick TH: Cardiac Stress
Testing and Imaging - a Clinician's Guide. New-York: Churchill Livingstone, 1996, 299-321.
DeFranco AC, Tuczu EM, Brener SJ, Nissen SE: Interventional Applications of Coronary
Intravascular Ultrasound, Angioscopy and Doppler Flow, in Ross R, Fuster V, and Topol EJ:
Atherosclerosis and Coronary Artery Disease, ch.90, 1451-1472, 1995, Raven Press, New York,
New York.
Brener SJ, and Stewart WS: Progression of Aortic Stenosis. Cardiology Board Review, 1995; 12:425.
Brener SJ, Lincoff AM, Topol EJ: An Update on Coronary Thrombolysis. Hosp Med 1993; 29(12):11.